Search
for
Sort by
Research 811–840 of 1000+
- Wnt signaling in skin organogenesis
- Beyond Expectations
- Nutrition and hair
- The Facial Adipose Tissue: A Revision
- Air Pollution, Autophagy, and Skin Aging: Impact of Particulate Matter (PM10) on Human Dermal Fibroblasts
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Alopecia areata: An update
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Androgen receptors and their biology
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Primary cicatricial alopecia
- Stability of opiates in hair fibers after exposure to cosmetic treatment
- Proteome Analysis of Human Sebaceous Follicle Infundibula Extracted from Healthy and Acne-Affected Skin
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- The role of lymphocytes in the development and treatment of alopecia areata
- Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
- An Overview of Alopecias
- The Functional Diversity of Epidermal Keratins Revealed by the Partial Rescue of the Keratin 14 Null Phenotype by Keratin 16
- Thehairless gene of the mouse: Relationship of phenotypic effects with expression profile and genotype
- The slick hair coat locus maps to chromosome 20 in Senepol-derived cattle
- Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen
- Alopecia Areata
- What controls hair follicle cycling?
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Cutaneous Manifestations of Eating Disorders
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Premature graying of hair
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- Adverse Cutaneous Reactions to Mood Stabilizers